Amboy Street Ventures Joins Granata Bio’s $14M Series A

Amboy Street Ventures (ASV) is excited to announce its latest investment in Granata Bio.

Top 10 Deals of 2023: Imaware Acquires Binx Health’s STI Testing Business

This week we assess the acquisition of Binx Health, an at-home STI testing company and consider similar pioneers in the sexual health space.

Top 10 Deals of 2023: Menopause Drug Intrarosa Acquired by Cosette Pharmaceuticals

This week we discuss what the acquisition of Intrarosa means for the industry and consider similar pioneers in the women’s health space.

Top 10 Deals of 2023: Evernow Raises a $28.5M Series A

This week we acknowledge Evernow’s fundraising success and highlight the positive impact they are making in the field of women’s health.

Top 10 Deals of 2023: Breast Cancer Therapeutic Company is Acquired by Gilead

This week we discuss what the acquisition of XinThera means for the industry and consider similar pioneers in the women’s health space.

Top 10 Deals of 2023: Kindbody Announces $100 Million Raise

This week we reflect on the remarkable trajectory of Kindbody’s growth, applauding their substantial fundraising achievements, underscoring the positivity it brings to the women’s health sector.

Top 10 Deals of 2023: Pregnancy Care Company, Nuvo Group, merges with LAMF Global Ventures

This week we discuss what the merger of Nuvo Group and LAMF Global Ventures means for the industry and consider similar pioneers in the women’s health space.

Top 10 Deals of 2023: Thorne HealthTech Acquired for $680M by L. Catterton

This week we discuss what the acquisition of Thorne HealthTech means for the industry and consider similar pioneers in the women’s health space.

Evvy, an Amboy Street Portfolio Company, Raises a $14M SeriesA

Amboy Street Ventures announces its latest investment in Evvy, a company committed to restoring equity in healthcare by leveraging overlooked female biomarkers, starting with the vaginal microbiome.

Fast track our industry.
Get in touch today.